Floatz logo

Tropisetron

Chronic Disease

Insel Gruppe AG, University Hospital BernSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Chronic Disease cohort.

Asset / SponsorPhaseRating
Velaglucerase Alfa
Shaare Zedek Medical Center
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
RIVER Foundation
Phase 4BB
NEPENTHE
Federal University of Paraíba
Phase 4BB
Asenapine
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec
Phase 4BB
Naltrexone
Pfizer
Phase 4BB

View all 39 →

Same molecule, other indications

Tropisetron is also rated in:

VomitingDormant
BB
Indicative ·
65 / 100
View asset →
Nausea and VomitingDormant
BB
Indicative ·
64 / 100
View asset →
nicotine dependenceDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →